Cargando…
Interaction and Inhibition of a Ganoderma lucidum Proteoglycan on PTP1B Activity for Anti-diabetes
[Image: see text] Protein tyrosine phosphatase 1B (PTP1B) is a key negative regulator of insulin and an effective target for the treatment of type 2 diabetes (T2D). A natural hyperbranched proteoglycan extracted from Ganoderma lucidum, namely, Fudan-Yueyang G. Lucidum (FYGL), was demonstrated capabl...
Autores principales: | Yu, Fanzhen, Wang, Yingxin, Teng, Yilong, Yang, Shutong, He, Yanming, Zhang, Zeng, Yang, Hongjie, Ding, Chuan-Fan, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582033/ https://www.ncbi.nlm.nih.gov/pubmed/34778653 http://dx.doi.org/10.1021/acsomega.1c04244 |
Ejemplares similares
-
Effects of a Ganoderma lucidum Proteoglycan
on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic
Islets
por: Yu, Fanzhen, et al.
Publicado: (2023) -
Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
por: Wang, YingXin, et al.
Publicado: (2023) -
Pancreatic cancer cell apoptosis is induced by a proteoglycan extracted from Ganoderma lucidum
por: Wu, Xiao, et al.
Publicado: (2021) -
Proteoglycan Extracted
from Ganoderma lucidum Ameliorated Diabetes-Induced
Muscle Atrophy via the AMPK/SIRT1 Pathway
In Vivo and In Vitro
por: Li, Jiaqi, et al.
Publicado: (2023) -
Modulation of energy metabolism and mitochondrial biogenesis by a novel proteoglycan from Ganoderma lucidum
por: Yang, Zhou, et al.
Publicado: (2019)